On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Inflammatory Biomarkers in Disease Prognosis

TopicLeading institutions, researchers & key papers

Inflammatory Biomarkers in Disease Prognosis is a topic indexed in ScholarIQ from OpenAlex.

What is known about Inflammatory Biomarkers in Disease Prognosis?

ScholarIQrecord summary

This cluster of papers explores the intricate relationship between inflammation and cancer, focusing on the role of immunity, systemic inflammatory response, platelets, and various prognostic markers in cancer development, progression, and treatment effectiveness. It delves into the mechanisms of inflammation-induced cancer, the impact of platelets on metastasis, and the potential of inflammatory pathways as therapeutic targets.

How many works does Inflammatory Biomarkers in Disease Prognosis have?

ScholarIQindexed works

Inflammatory Biomarkers in Disease Prognosis has 365 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Inflammatory Biomarkers in Disease Prognosis?

ScholarIQopenalex

The OpenAlex for Inflammatory Biomarkers in Disease Prognosis is on the source record.

What are the most-cited papers on Inflammatory Biomarkers in Disease Prognosis?

ScholarIQmost cited works
Relation Between Red Blood Cell Distribution Width and Inflammatory Biomarkers in a Large Cohort of Unselected Outpatients
Giuseppe Lippi, Giovanni Targher, Martina Montagnana, Gian Luca Salvagno, Giacomo Zoppini, Gian Cesare Guidi
Archives of Pathology & Laboratory Medicine. 2009988 Citations
Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure
G. Michael Felker, Larry A. Allen, Stuart Pocock, Linda K. Shaw, John J.V. McMurray, Marc A. Pfeffer, Karl Swedberg, Duolao Wang, Salim Yusuf, Eric L. Michelson, Christopher B. Granger
Journal of the American College of Cardiology. 2007955 Citations
Systemic immune‐inflammation index (SII) predicted clinical outcome in patients with coronary artery disease
Ya‐Ling Yang, Cheng‐Hsueh Wu, Pai‐Feng Hsu, Su‐Chan Chen, Shao‐Sung Huang, Wan Leong Chan, Shing‐Jong Lin, Chia‐Yu Chou, Jaw‐Wen Chen, Ju‐Pin Pan, Min‐Ji Charng, Ying‐Hwa Chen, Tao‐Cheng Wu, Tse‐Min Lu, Po‐Hsun Huang, Hao‐Min Cheng, Chin‐Chou Huang, Shih‐Hsien Sung, Yenn‐Jiang Lin, Hsin‐Bang Leu
European Journal of Clinical Investigation. 2020702 Citations
Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients
Brandon L. Pierce, Rachel Ballard‐Barbash, Leslie Bernstein, Richard Baumgartner, Marian L. Neuhouser, Mark H. Wener, Kathy B. Baumgartner, Frank D. Gilliland, Bess Sorensen, Anne McTiernan, Cornelia M. Ulrich
Journal of Clinical Oncology. 2009695 CitationsOPEN ACCESS
Red Blood Cell Distribution Width and Mortality Risk in a Community-Based Prospective Cohort
Todd S. Perlstein, Jennifer Weuve, Marc A. Pfeffer, Joshua A. Beckman
Archives of Internal Medicine. 2009537 Citations

Where is Inflammatory Biomarkers in Disease Prognosis research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Inflammatory Biomarkers in Disease Prognosis is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
13%
Green
13%
Hybrid
7%
Bronze
27%
Closed
40%

Related on ScholarIQ

470M+ articles · 14-day free trial